Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

Trial ID or NCT#

NCT01860963

Status

not recruiting iconNOT RECRUITING

Purpose

This study is designed to establish the prevalence of anal squamous intraepithelial lesion (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.

Official Title

Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

Eligibility Criteria

Ages Eligible for Study: 18 Years to 85 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - All IBD patients followed in the IBD clinic and healthy controls who are greater than 18 years old
Exclusion Criteria:
  1. - History of HPV vaccination - Pregnancy - Other immunosuppressed states (i.e. systemic lupus erythematosus, rheumatoid arthritis, cancer, Human Immunodeficiency Virus (HIV), transplant) - IBD patients who don't meet immunosuppression/non-immunosuppression criteria - Inability to obtain informed consent from patient - Previous diagnosis of ASIL or anal/rectal cancer

Contact us to find out if this trial is right for you.

Contact

Shamita Shah, MD
650-736-0431